
GHK is Gly-His-Lys.[1] AHK is Ala-His-Lys, as identified in the accessible AHK-Cu study abstract; only the abstract was reviewed, not the full paper.[2] The N-terminal residue therefore differs: glycine in GHK, alanine in AHK. The four sources consulted for this comparison do not establish which peptide binds Cu(II) more strongly. A GHK coordination model should not be assigned to AHK without direct evidence.
The sequence difference is small; the evidence is not interchangeable
| Comparison | GHK-Cu | AHK-Cu |
|---|---|---|
| Peptide sequence | Gly-His-Lys.[1] | Ala-His-Lys.[2] |
| Evidence reviewed | A review of GHK coordination, an abstract on GHK analogues, and a full paper on a GHK/co-ligand system.[1,3,4] | An accessible abstract describing cell and ex-vivo assays; the full paper was not reviewed.[2] |
| What the sources support | Source-specific descriptions of coordination, complex formation, and solution speciation.[1,3,4] | Identification of the reported complex and assay contexts, within the abstract’s scope.[2] |
| Unresolved comparison | No direct quantitative GHK-versus-AHK Cu(II) binding comparison was found in this source set. | No binding ranking or equivalent coordination behavior can be established from the reviewed abstract. |
The numbered sources in this matrix are discussed and linked below. The matrix compares the evidence available here; it does not rank the materials’ performance.
What the literature supports about GHK-Cu

The reviewed coordination model involves the Gly N-terminal amino group, a backbone amide, and histidine. At physiological pH, in the specific GHK model described by the review, the Lys side-chain amino group is protonated and does not participate in coordination. This statement describes that model, rather than every possible GHK-containing solution.[1]
The abstract of Conato and colleagues’ analogue study reports differences in copper-complex stoichiometry and stability, along with pH-dependent Lys side-chain participation. Its two synthetic analogues replace histidine; neither is AHK.[3] That distinction changes the interpretation: evidence about replacing His does not directly answer what happens when the N-terminal Gly is replaced by Ala.
A separate full-text study examines a ternary Cu(II) complex containing GHK and cis-urocanic acid. Its speciation analysis concerns that defined peptide/co-ligand system; it is not an AHK experiment.[4]
For literature review, keep the chemical conditions beside the reported result. A coordination description, a stability measurement, and a solution-speciation analysis answer different questions. The GHK sources above illustrate why pH and co-ligands belong in the comparison rather than being omitted from a single headline binding claim.[3][4]
What AHK-Cu studies measure—and what they do not
The AHK-Cu example here is limited to the accessible abstract of Pyo and colleagues’ 2007 study; the full paper was not reviewed. The abstract identifies L-alanyl-L-histidyl-L-lysine–Cu(II) and describes cultured dermal papilla cells and ex-vivo human hair-follicle preparations.[2]
Read this example in four parts:
- Reported material: AHK-Cu, identified by its peptide sequence and Cu(II) designation.
- Reported context: cultured cells and ex-vivo follicle preparations.
- Missing from the reviewed abstract: a Cu(II) binding constant, a coordination-geometry assignment, a solution-speciation analysis, and a quantitative matched comparison with GHK.
- Conclusion available here: the abstract documents those laboratory assay contexts. It does not supply the measurements needed to rank AHK against GHK for copper binding. This assessment is based only on the abstract, not a full-paper review.[2]
The evidence gap in a GHK-Cu versus AHK-Cu comparison

No direct quantitative GHK-versus-AHK Cu(II) binding comparison was found in the four-source set reviewed here. That is a limit of this review, not a claim that no such study exists.
When assessing a proposed comparison, use the following as a documentation checklist:
- Confirm identity. Record the peptide sequence and chemical form actually tested. An analogue study must change the residue relevant to the question.
- Identify the measurement. Separate a binding or coordination measurement from a cellular or ex-vivo readout.
- Compare conditions. Look for both peptides tested with documented pH, medium, concentrations, copper-to-peptide ratios, and co-ligands.
- Check comparability. Before ranking reported values, examine whether the methods and chemical models permit that comparison.
No batch-matched identity, composition, or analytical documentation was supplied for a commercial material. This article therefore makes no product or batch claims. For procurement review, obtain documentation tied to the material under consideration rather than treating a literature description as its test result.
Related research: GHK-Cu Salt Forms Explained: GHK vs GHK-Cu, Acetate vs HCl, 1:1 vs 2:1, Prezatide Copper and the Copper-Ratio Check; What Is AHK-Cu? The Alanine–Histidine–Lysine Copper Peptide; What Is GHK-Cu? Copper Binding, Cell Studies, and Research Evidence; AHK-CU.
参考来源
- Metal-dependent hormone function: the emerging interdisciplinary field of metalloendocrinology
- The effect of tripeptide-copper complex on human hair growth in vitro — abstract reviewed only
- Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity — abstract reviewed only
- Ternary Cu(II) Complex with GHK Peptide and Cis-Urocanic Acid as a Potential Physiologically Functional Copper Chelate
Research Use Only Disclaimer
This article is for laboratory research and analytical education only. It is not a validated experimental protocol or medical or veterinary advice, and it provides no instructions for human or animal administration.